[go: up one dir, main page]

NO20020084L - Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse - Google Patents

Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Info

Publication number
NO20020084L
NO20020084L NO20020084A NO20020084A NO20020084L NO 20020084 L NO20020084 L NO 20020084L NO 20020084 A NO20020084 A NO 20020084A NO 20020084 A NO20020084 A NO 20020084A NO 20020084 L NO20020084 L NO 20020084L
Authority
NO
Norway
Prior art keywords
sustained release
release compositions
salt
processes
preparation
Prior art date
Application number
NO20020084A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020084D0 (no
Inventor
Yasutaka Igari
Yoshio Hata
Kazumichi Yamamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20020084D0 publication Critical patent/NO20020084D0/no
Publication of NO20020084L publication Critical patent/NO20020084L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020084A 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse NO20020084L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20188799 1999-07-15
PCT/JP2000/004683 WO2001005380A1 (fr) 1999-07-15 2000-07-13 Compositions a liberation lente, techniques de production et methodes d'utilisation

Publications (2)

Publication Number Publication Date
NO20020084D0 NO20020084D0 (no) 2002-01-08
NO20020084L true NO20020084L (no) 2002-03-14

Family

ID=16448493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020084A NO20020084L (no) 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Country Status (21)

Country Link
US (2) US7265157B1 (de)
EP (1) EP1197208B1 (de)
KR (1) KR20020012312A (de)
CN (1) CN1361685A (de)
AT (1) ATE360413T1 (de)
AU (1) AU5853000A (de)
BR (1) BR0012400A (de)
CA (1) CA2378714A1 (de)
CZ (1) CZ2002114A3 (de)
DE (1) DE60034568T2 (de)
HK (1) HK1042237A1 (de)
HU (1) HUP0202880A3 (de)
IL (1) IL147417A0 (de)
MX (1) MXPA02000461A (de)
NO (1) NO20020084L (de)
NZ (1) NZ516466A (de)
PL (1) PL352499A1 (de)
RU (1) RU2002103718A (de)
SK (1) SK342002A3 (de)
WO (1) WO2001005380A1 (de)
ZA (1) ZA200200347B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ505651A (en) * 1998-01-16 2003-08-29 Takeda Chemical Industries Ltd Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
CA2355186C (en) * 1998-12-15 2008-03-18 Takeda Chemical Industries, Ltd. Process for producing polymer
CN1269870C (zh) 2000-08-07 2006-08-16 和光纯药工业株式会社 乳酸聚合物及其制备方法
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales
CA2444727A1 (en) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Agents for preventing postoperative recurrence of premenopausal breast cancer
US6693134B2 (en) 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
KR100994658B1 (ko) * 2001-12-26 2010-11-16 다케다 야쿠힌 고교 가부시키가이샤 신규 마이크로스피어 및 이들의 제조 방법
CA2490351C (en) 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
WO2005009357A2 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
US20050064045A1 (en) * 2003-09-18 2005-03-24 Sheng-Ping Zhong Injectable therapeutic formulations
US7906125B2 (en) 2003-09-18 2011-03-15 Boston Scientific Scimed, Inc. Solid or semi-solid therapeutic formulations
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
EP1679065A1 (de) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
US20070149457A1 (en) * 2005-12-13 2007-06-28 Byron Rubin Stable solid forms of enterostatin
AU2006326502A1 (en) * 2005-12-13 2007-06-21 Harkness Pharmaceuticals, Inc. Methods of treating obesity using enterostatin
EP2051725A4 (de) * 2006-07-11 2011-06-15 Harkness Pharmaceuticals Inc Verfahren zur behandlung von fettsucht mit sättigungsfaktoren
US7858663B1 (en) * 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
EA016176B1 (ru) 2006-12-18 2012-02-28 Такеда Фармасьютикал Компани Лимитед Композиция с замедленным высвобождением и способ её получения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4459196A (en) 1995-01-23 1996-08-14 Takeda Chemical Industries Ltd. Sustained-release preparation and use
CA2219698C (en) 1996-10-31 2007-09-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
NZ505651A (en) 1998-01-16 2003-08-29 Takeda Chemical Industries Ltd Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
JPH11269094A (ja) * 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
CA2355186C (en) * 1998-12-15 2008-03-18 Takeda Chemical Industries, Ltd. Process for producing polymer

Also Published As

Publication number Publication date
ATE360413T1 (de) 2007-05-15
US20080014237A1 (en) 2008-01-17
PL352499A1 (en) 2003-08-25
US7265157B1 (en) 2007-09-04
NO20020084D0 (no) 2002-01-08
HUP0202880A3 (en) 2003-04-28
WO2001005380A1 (fr) 2001-01-25
DE60034568T2 (de) 2008-01-03
MXPA02000461A (es) 2002-07-30
CZ2002114A3 (cs) 2002-04-17
HUP0202880A2 (hu) 2003-01-28
RU2002103718A (ru) 2003-10-10
DE60034568D1 (de) 2007-06-06
AU5853000A (en) 2001-02-05
NZ516466A (en) 2003-02-28
BR0012400A (pt) 2002-05-21
ZA200200347B (en) 2003-03-26
EP1197208B1 (de) 2007-04-25
CA2378714A1 (en) 2001-01-25
HK1042237A1 (en) 2002-08-09
CN1361685A (zh) 2002-07-31
KR20020012312A (ko) 2002-02-15
EP1197208A1 (de) 2002-04-17
IL147417A0 (en) 2002-08-14
EP1197208A4 (de) 2004-06-30
SK342002A3 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
NO20020084L (no) Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse
HUP0100221A2 (hu) Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
CY1117889T1 (el) Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου
WO2001019780A3 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
DK0839525T3 (da) Præparat med forlænget frigivelse
CA2107709A1 (en) Calcium Agent for Plants
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
WO1999057301A8 (en) Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
MY139606A (en) Sustained-release composition and process for producing the same
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
CA2336412A1 (en) Medicament for treatment of diabetes
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
EP2239270A3 (de) Peptidderivate mit geringem Molekulargewicht als Inhibitoren der Laminin/Nidogen-Wechselwirkung
JP2001510860A5 (de)
WO2002030874A3 (en) Aliphatic, cyclic amino carboxylic acids as integrin antagonists
JP4699635B2 (ja) 徐放性薬剤組成物
DE69908771D1 (de) Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
TH101402B (th) สารผสมที่ออกฤทธิ์นาน และกรรมวิธีสำหรับผลิตสารเดียวกันนี้
TH62985A (th) สูตรผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application